You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resected early stage Non-small Cell Lung Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Identify Resected Non-small-cell Lung Cancer With High Risk of

Recruiting
  • Non-small Cell Lung Cancer Stage IIIA
  • Resected non small cell lung cancer
  • Toulouse, France
    Julien MAZIERES
Feb 8, 2023

NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

Recruiting
  • Non-small Cell Lung Cancer
  • SH-1028 tablets
  • Placebo SH-1028 tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 6, 2023

NSCLC Trial in Shanghai

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 20, 2023

    Lung Tumor Malignant Trial in Milano (SBRT, Surgery)

    Not yet recruiting
    • Lung Neoplasm Malignant
    • SBRT
    • Surgery
    • Milano, MI, Italy
      Istituto Europeo di Oncologia IRCCS
    Jul 26, 2023

    NSCLC Trial (V940, Pembrolizumab, Placebo)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • V940
    • +2 more
    • (no location specified)
    Oct 5, 2023

    Resectable Lung Non-Small Cell Carcinoma Trial in Atlanta (procedure, radiation, other)

    Not yet recruiting
    • Resectable Lung Non-Small Cell Carcinoma
    • Biospecimen Collection
    • +2 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Aug 22, 2023

    Aggressive Histological Pattern in Resected Non-small Cell Lung

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • PET/CT-based Deep Learning Signature
    • Zunyi, Guizhou, China
    • +2 more
    Jun 27, 2023

    Early Stage NSCLC, NSCLC Trial in Saint Louis (Computed tomography-guided stereotactic adaptive radiotherapy, ETHOS)

    Not yet recruiting
    • Early Stage Non-small Cell Lung Cancer
    • Non-small Cell Lung Cancer
    • Computed tomography-guided stereotactic adaptive radiotherapy
    • ETHOS
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 14, 2023

    Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

    Not yet recruiting
    • Stage III NSCLC
    • Surgery
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Feb 21, 2023

    Double-dose Furmonertinib in Treatment of Slow

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • (no location specified)
    Oct 31, 2023

    NSCLC Trial in Philadelphia (device, drug, other)

    Not yet recruiting
    • NSCLC
    • Aliya Pulsed Electric Fields (PEF) ablation
    • +3 more
    • Philadelphia, Pennsylvania
      Temple University
    Oct 24, 2022

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    NSCLC Trial in Changchun (Almonertinib, Placebo Almonertinib)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Changchun, Jilin, China
      Jilin Province Cancer Hospital
    Jun 13, 2022

    Non Small Cell Lung Cancer, Stage I Lung Cancer, Stage Ib Lung Carcinoma Trial in Winston-Salem (Vitamin A Compound, Therapeutic

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • +5 more
    • Vitamin A Compound
    • Therapeutic Conventional Surgery
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Jan 5, 2023

    NSCLC Trial (Dupilumab, Cemiplimab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Dupilumab
    • Cemiplimab
    • (no location specified)
    Oct 12, 2023

    NSCLC Trial in Beijing

    Recruiting
    • NSCLC
      • Beijing, China
        Yuyan Wang
      Oct 10, 2023

      Extensive Stage Small Cell Lung Cancer

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
        • Changsha, Hunan, China
          Hunan Cancer hospital
        Aug 6, 2023

        Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

        Not yet recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • +2 more
        • Cetuximab
        • +2 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 2, 2023

        NSCLC Trial in Shanghai (Carbon ion beam radiotherapy)

        Recruiting
        • Non-small Cell Lung Cancer
        • Carbon ion beam radiotherapy
        • Shanghai, Shanghai, China
          Shanghai Proton and Heavy Ion Center
        Nov 10, 2022

        Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

        Not yet recruiting
        • Stage IIIB(N2) Non-small Cell Lung Cancer
        • +3 more
        • Pembrolizumab 200 mg IV infusion
        • Beijing, Beijing, China
          Peking University
        May 30, 2023

        Stage IB Non-small Cell Lung Cancer

        Completed
        • Stage IB Non-Small Cell Lung Carcinoma
          • Shanghai, China
            180 Fenglin Road
          Jul 29, 2023

          Early Stage NSCLC Trial in Philadelphia (Vancomycin, Stereotactic Body Radiation Therapy (SBRT))

          Recruiting
          • Early Stage Non-Small Cell Lung Cancer
          • Vancomycin
          • Stereotactic Body Radiation Therapy (SBRT)
          • Philadelphia, Pennsylvania
            Abramson Cancer Center of the University of Pennsylvania
          Nov 1, 2022

          Resectable Early-stage Non-small Cell Lung Cancer

          Completed
          • Non-small Cell Lung Cancer
            • Alexandria, Egypt
            • +3 more
            Nov 21, 2022

            Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

            Recruiting
            • Nonsmall Cell Lung Cancer
            • +3 more
            • Genomically Guided Radiation Therapy (RT)
            • Tampa, Florida
              Moffitt Cancer Center
            May 23, 2023

            NSCLC, Stage I Trial (Tislelizumab monotherapy)

            Not yet recruiting
            • NSCLC, Stage I
            • Tislelizumab monotherapy
            • (no location specified)
            Mar 9, 2022